MCRB earnings: a negative outcome, -7.0%

On March 5, 2024, Seres Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.0% in the window around the event. It had already run +11.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.